Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Unicycive Therapeutics, Inc. (UNCY) had Normalized Income after Taxes of $-1.72M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-1.72M |
|
-- |
|
-- |
|
$10.14M |
|
$-10.14M |
|
$8.42M |
|
$-1.72M |
|
$-1.72M |
|
$-1.72M |
|
$-1.72M |
|
$-1.72M |
|
|
Normalized Income after Taxes |
$-1.72M |
$-10.14M |
|
$-10.02M |
|
26.92M |
|
26.92M |
|
$-0.06 |
|
$-0.06 |
|
| Balance Sheet Financials | |
$71.32M |
|
$0.04M |
|
$0.71M |
|
$72.03M |
|
$18.70M |
|
-- |
|
$0.06M |
|
$18.76M |
|
$53.27M |
|
$53.27M |
|
$53.27M |
|
27.86M |
|
| Cash Flow Statement Financials | |
$-13.85M |
|
$-5.18M |
|
$34.01M |
|
$29.20M |
|
$44.19M |
|
$14.99M |
|
$3.63M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.81 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-13.85M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-3.23% |
|
-3.23% |
|
-2.39% |
|
-3.23% |
|
$1.91 |
|
$-0.51 |
|
$-0.51 |
|